Cargando…
Can detection and prediction models for Alzheimer’s Disease be applied to Prodromal Parkinson’s Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures.
Parkinson's disease (PD) is the fastest growing neurodegeneration and has a prediagnostic phase with a lot of challenges to identify clinical and laboratory biomarkers for those in the earliest stages or those 'at risk'. Despite the current research effort, further progress in this fi...
Autores principales: | Tarnanas, Ioannis, Vlamos, Panagiotis, Harms, Dr Robbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445877/ https://www.ncbi.nlm.nih.gov/pubmed/37645162 http://dx.doi.org/10.12688/openreseurope.14216.2 |
Ejemplares similares
-
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer’s disease: the Altoida large cohort study
por: Meier, Irene B., et al.
Publicado: (2021) -
The prodromes of Parkinson's disease
por: Rees, Richard Nathaniel, et al.
Publicado: (2018) -
Associations of digital neuro-signatures with molecular and neuroimaging measures of brain resilience: The altoida large cohort study
por: Seixas, Azizi A., et al.
Publicado: (2022) -
Novel modeling methodologies for the neuropathological dimensions of Parkinson's disease
por: Vlamos, Panagiotis
Publicado: (2020) -
The Concept of Prodromal Parkinson’s Disease
por: Mahlknecht, Philipp, et al.
Publicado: (2015)